Vehreschild JJ - Search Results

1

Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.

Vehreschild JJ, Cornely OA. Vehreschild JJ, et al. Future Microbiol. 2006 Aug;1(2):161-70. doi: 10.2217/17460913.1.2.161. Future Microbiol. 2006. PMID: 17661660 Review.

2

Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.

Vehreschild JJ, Krüger K, Kurzai O, Wickenhauser C, Behringer K, Töx U, Cornely OA. Vehreschild JJ, et al. Mycoses. 2006;49 Suppl 1:42-7. doi: 10.1111/j.1439-0507.2006.01302.x. Mycoses. 2006. PMID: 16961582

3

Severe pneumonia and human bocavirus in adult.

Kupfer B, Vehreschild J, Cornely O, Kaiser R, Plum G, Viazov S, Franzen C, Tillmann RL, Simon A, Müller A, Schildgen O. Kupfer B, et al. Emerg Infect Dis. 2006 Oct;12(10):1614-6. doi: 10.3201/eid1210.060520. Emerg Infect Dis. 2006. PMID: 17176591 Free PMC article. No abstract available.

4

Anidulafungin--state of affairs from a clinical perspective.

Vehreschild JJ, Kümmerle T, Karthaus M, Cornely OA. Vehreschild JJ, et al. Mycoses. 2007;50 Suppl 1:38-43. doi: 10.1111/j.1439-0507.2007.01378.x. Mycoses. 2007. PMID: 17394608 Review.

5

Zygomycosis--current epidemiological aspects.

Glöckner A, Vehreschild JJ, Cornely OA. Glöckner A, et al. Among authors: vehreschild jj. Mycoses. 2007;50 Suppl 1:50-5. doi: 10.1111/j.1439-0507.2007.01380.x. Mycoses. 2007. PMID: 17394610 Review.

6

Fatal pneumonia associated with human metapneumovirus (HMPV) in a patient with myeloid leukemia and adenocarcinoma in the lung.

Müller A, Kupfer B, Vehreschild J, Cornely O, Kaiser R, Seifert H, Viazov S, Tillmann RL, Franzen C, Simon A, Schildgen O. Müller A, et al. Eur J Med Res. 2007 Apr 26;12(4):183-4. Eur J Med Res. 2007. PMID: 17509965

7

Posaconazole: a next-generation triazole antifungal.

Farowski F, Vehreschild JJ, Cornely OA. Farowski F, et al. Among authors: vehreschild jj. Future Microbiol. 2007 Jun;2(3):231-43. doi: 10.2217/17460913.2.3.231. Future Microbiol. 2007. PMID: 17661696

8

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).

Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA. Vehreschild JJ, et al. J Infect. 2007 Nov;55(5):445-9. doi: 10.1016/j.jinf.2007.07.003. Epub 2007 Sep 6. J Infect. 2007. PMID: 17822770 Clinical Trial.

9

Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.

Vehreschild JJ, Böhme A, Reichert D, Kiehl MG, Arenz D, Pankraz K, Kochanek M, Ullmann AJ, Cornely OA. Vehreschild JJ, et al. Int J Hematol. 2008 Mar;87(2):126-131. doi: 10.1007/s12185-008-0045-z. Epub 2008 Feb 21. Int J Hematol. 2008. PMID: 18288564 Free PMC article.

10

Antifungal treatment strategies in high risk patients.

Rüping MJ, Vehreschild JJ, Cornely OA. Rüping MJ, et al. Among authors: vehreschild jj. Mycoses. 2008 Sep;51 Suppl 2:46-51. doi: 10.1111/j.1439-0507.2008.01572.x. Mycoses. 2008. PMID: 18721331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters